Ovarian Cancer Treatment Drugs Market Size, Share, Trend, Forecast, & Industry Analysis: 2021-2026
See less
Ovarian Cancer Treatment Drugs Market Size, Share, Trend, Forecast, & Industry Analysis: 2021-2026
Ovarian Cancer Treatment Drugs Market, By Drugs (PARP Inhibitors, Angiogenesis Inhibitors, PD-L1 Inhibitors), By End Use (Hospitals, Ambulatory Surgical Centers, Clinics), and Region - COVID-19 Impact Analysis and Forecast to 2026
Ovarian Cancer Treatment Drugs Market, By Drugs (PARP Inhibitors, Angiogenesis Inhibitors, PD-L1 Inhibitors), By End Use (Hospitals, Ambulatory Surgical Centers, Clinics), and Region - COVID-19 Impact Analysis and Forec...
The Ovarian Cancer Treatment Drugs Market is estimated to grow from USD 3.0 billion in 2020 to USD 10.5 billion by 2026 at a healthy CAGR of 23.9% during the forecast period.
Ovarian Cancer Treatment Drugs Market- Research Scope
Base Year of Study
2020
Trend Period
2015-2019
Forecast Period
2021-2026
Market Size in 2020
US$ 3.0 billion
Market Size in 2026
US$ 10.5 billion
Market Growth (2021-2026)
23.9% CAGR
Figure: Ovarian Cancer Treatment Drugs Market Size, 2020-2026 (USD Billion)
Ovarian cancer affects the ovaries. It is one of the most dreadful type of cancer found among women. In this cancer, abnormal cells growth is witnessed in the ovaries, which can invade and adversely affect other body parts such as lining of the bowel & bladder, abdomen layers, lymph nodes, and liver. The treatment for ovarian cancer is done with help of drugs such as PARP inhibitors, angiogenesis inhibitors. Etc.
Covid-19 Impact Analysis
The COVID-19 pandemic has negatively influenced the ovarian cancer treatment drugs industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to meet the ever-growing coronavirus patient pool. The diagnostic and ovarian cancer treatment declined due to fear of coronavirus infection.
Key Players
Key players operating in the global Ovarian Cancer Treatment Drugs Market are-
AstraZeneca (UK)
Roche/ Genentech (Switzerland)
Tesaro (US)
Clovis Oncology (US)
Kazia Therapeutics (Australia)
Polaris Pharma (US)
Market Dynamics
The Ovarian Cancer Treatment Drugs market is majorly driven by rising incidence of ovarian cancer cases. Also, the growing need for more effective treatment options augments the market growth in the coming years. Moreover, significant development of drugs with enhanced efficacy and strong R&D investments further increases the market potential, during the review period.
Segment’s Analysis
End UseTrends
Based on end use, the ovarian cancer treatment drugs market has been classified into hospitals, ambulatory surgical centers, and clinics. The hospitals segment accounted for the largest market in 2020 owing to presence of well-established medical infrastructure in hospital settings coupled with highly qualified oncologists and medical professionals.
Regional Trends
By region, the North America Ovarian Cancer Treatment Drugs market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period. The Ovarian Cancer Treatment Drugs market growth is mainly attributed to surge in healthcare expenditure, technologically advanced healthcare infrastructure, and well-established medical companies. Moreover, growing healthcare expenditure and rising prevalence of ovarian cancer cases, sedentary lifestyles of individuals, thus augmenting the market growth.
The Asia Pacific Ovarian Cancer Treatment Drugs market is expected to grow at the healthy CAGR during the review period due to growing healthcare expenditure in emerging countries, rising ovarian cancer cases, and increasing awareness regarding early detection of cancer in emerging countries of China and India, further bolsters the regional market growth.
Critical Questions Answered in the Report
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global ovarian cancer treatment drugs market. The historic years considered for the study are 2016-2019, base year is 2020, estimated year is 2021, and forecast period is 2022-2026. Following are the critical questions answered in the report.
What are the key trends in the global ovarian cancer treatment drugs market?
How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
What is the impact of COVID-19 on global ovarian cancer treatment drugs market?
What are the key strategies adopted by the major vendors to lead in the global ovarian cancer treatment drugs market?
The target audience of Ovarian Cancer Treatment Drugs Market includes-
Ovarian Cancer Treatment Drugs Vendors
Ovarian Cancer Treatment Drugs Manufacturers
Ovarian Cancer Treatment Drugs Distributors
Organizations
Government Bodies.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
The Global Ovarian Cancer Treatment Drugs Market is estimated to grow from USD 3.0 billion in 2020 to USD 10.5 billion by 2026 at a healthy CAGR of 23.9% during the forecast period.
North America Ovarian Cancer Treatment Drugs market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period.
The target audience of Ovarian Cancer Treatment Drugs Market includes- Ovarian Cancer Treatment Drugs Vendors, Ovarian Cancer Treatment Drugs Manufacturers, Ovarian Cancer Treatment Drugs Distributors, Organizations, Government Bodies.
